CG
LMAT icon

Cynosure Group’s LeMaitre Vascular LMAT Stock Holding History

Cynosure Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,926
Closed -$431K – 472
2025
Q3 		$431K Hold
4,926
– – 0.05% 250
2025
Q2 		$409K Buy
4,926
+1,217
+33% +$102K 0.05% 270
2025
Q1 		$311K Buy
3,709
+440
+13% +$40.9K 0.04% 344
2024
Q4 		$301K Sell
3,269
-656
-17% -$63.1K 0.05% 235
2024
Q3 		$365K Sell
3,925
-711
-15% -$61.6K 0.05% 307
2024
Q2 		$381K Buy
4,636
+91
+2% +$6.68K 0.06% 246
2024
Q1 		$302K Buy
+4,545
New +$280K 0.05% 300

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cynosure Group's LMAT Position: Q4 2025 in Review

Cynosure Group sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 4,926 shares — an estimated $431K sold.

Cynosure Group first reported a position in LMAT in Q1 2024 and held it in 7 quarters. The position peaked at $431K in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Cynosure Group reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 4,926 LeMaitre Vascular shares in Q4 2025, an estimated $431K.
  • Cynosure Group first reported a position in LeMaitre Vascular in Q1 2024 and held it in 7 quarters.
  • Cynosure Group's LeMaitre Vascular position peaked at $431K in Q3 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.